Biosimilars Europe 2016 Conference

Proudly Sponsored by: Abzena

SMi Group is thrilled to present the 7th annual conference, Biosimilars Europe , taking place on 29th & 30th September 2016 in Central London, UK. Gathering an audience of principle scientists and regulatory experts involved in biotechnology and compliance, Biosimilars Europe 2016 will provide a perfect platform to discuss global market developments and strategies to market access.

Created with a top panel of industry thought leaders, this year's event will capture expert insight by honing in on the biosimilar product life-cycle from early stage developments, protein characterisation, and pricing & reimbursement; through to emerging markets and global developments.

Join us this autumn to arm yourself with the key requirements and tools for successful market entry through strategic direction on commercialisation; insight into potential therapeutic areas; and guidance on product quality assessment (PQA) in biosimilar development.

OUR NOTABLE SPEAKER LINE-UP WILL INCLUDE:

•    Huiguo Hu, General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co Ltd
•    Dr Niraj Chhaya, Risk Management, Boehringer Ingelheim GmbH
•    Atanas Dimitrov, Head of Strategy & Portfolio Management, Merck Group
•    Dr Alok Sharma, Head, Bio-Analytical Development, Lupin Ltd
•    Dr Andrea Laslop, Head of Scientific Office, Austrian Agency for Health and Food Safety
•    Joan O’Callaghan, Research Scientist for Regulatory Science Ireland, Health Products Regulatory Authority, Ireland

WHY YOU NEED TO BE THERE IN 2016:

•    Hear how the evolving regulatory landscape and guidelines will impact on biosimilars 
•    Overcome market access and commercialisation barriers 
•    Assess market trends and align your business strategy on emerging markets 
•    Technical updates on protein characterisation and analytical comparability to speed up data collection

PREVIOUS ATTENDEE TESTIMONIALS:

"Really wide range of topics" - Kantar Health
"Rich in information and quality speakers" - Globyz Pharma
"Great discussions, networking and education" - Apobiologix 
"Interesting mix of scientists, legal and commercial folk" - Allergan
"Impressive - beat my expectations" – Teva